Considering assembloids and organoids
A conference organized by Stanford University tackled bioethical questions raised by new technologies for replicating brain parts in a dish
Bruce Goldman
A better Alzheimer’s drug?
A long trek nears its destination
Infection connections
How past microbial incursions can lead to neurodegenerative diseases
Breaking the cycle
Innovations to alleviate the chronic disease crisis
COVID’s unwitting enablers?
New research flags unexpected cells in lungs as a suspected source of severe COVID
Why is a common gene variant bad for your brain?
The answer offers clues for a new kind of Alzheimer’s drug
The bigger the bucks, the bigger the (dopamine) bang
One reason we make bad decisions
Autoimmunity’s XX factor
Molecule can set off immune response in women
Where is ‘I’
The physical sense of self has been localized
Can we get along?
Humans versus artificial intelligence